Form 4 Tracker
Terrance P. Coyne

EVP & CFO · 9 filings · Latest: May 6, 2026

Royalty Pharma plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RPRX
Terrance P. CoyneEVP & CFOApr 28, 2026
Sale
$49.7834,791$1.7M40,136
RPRX
Terrance CoyneApr 28, 2026
Proposed Sale
$49.5434,791$1.7M
RPRX
Terrance P. CoyneEVP & CFOApr 1, 2026
Sale
$48.3334,791$1.7M32,916
RPRX
Terrance CoyneApr 1, 2026
Proposed Sale
$48.4934,791$1.7M
RPRX
Terrance P. CoyneEVP & CFOMar 23, 2026
Sale
$45.5334,791$1.6M43,886
RPRX
Terrance CoyneMar 23, 2026
Proposed Sale
$45.6134,791$1.6M
RPRX
Terrance P. CoyneEVP & CFOMar 2, 2026
Sale
$46.7834,791$1.6M45,761
RPRX
Terrance CoyneMar 2, 2026
Proposed Sale
$47.4734,791$1.7M
RPRX
Terrance P. CoyneEVP & CFOFeb 23, 2026
Sale
$45.3234,791$1.6M47,636
RPRX
Terrance CoyneFeb 23, 2026
Proposed Sale
$45.4734,791$1.6M
RPRX
Terrance P. CoyneEVP & CFOFeb 4, 2026
Sale
$43.2920,163$872.9K22,885
RPRX
Terrance P. CoyneEVP & CFOFeb 3, 2026
Sale
$42.84114,954$4.9M23,972
RPRX
Terrance P. CoyneEVP & CFOFeb 2, 2026
Sale
$42.08108,424$4.6M30,167
RPRX
Terrance CoyneFeb 3, 2026
Proposed Sale
$42.97135,117$5.8M
RPRX
Terrance CoyneFeb 2, 2026
Proposed Sale
$42.36108,424$4.6M
RPRX
Terrance P. CoyneEVP & CFOJan 20, 2026
Sale
$39.3569,582$2.7M36,010
RPRX
Terrance CoyneJan 20, 2026
Proposed Sale
$39.0969,582$2.7M
RPRX
Terrance CoyneJan 2, 2026
Proposed Sale
$38.8669,582$2.7M
RPRX
Terrance CoyneDec 15, 2025
Proposed Sale
$38.5369,582$2.7M
RPRX
Terrance CoyneDec 1, 2025
Proposed Sale
$39.9069,582$2.8M

Page 1 of 2

Next →